Happy to report a new TRPV1 agonist MSP20, which binds to the vanilloid site and desensitizes TRPV1. Our structural and preclinical studies highlight the potential of MSP20 as a long-lasting analgesic with neuroprotective effects. nature.com/articles/s41467-0โฆ
๐ Biomedicines, Pharmaceutics & Pharmaceuticals are honoring 2025's best young investigators! Join the award ceremony on 22 May 2026, 17:00 CEST. Free access! ๐
sciforum.net/event/Topics-49